Bacteriocins: New Potential Therapeutic Candidates in Cancer Therapy

Area of Science:

• Microbiology
• Oncology
• Biotechnology

Background:

• Cancer presents a significant global health challenge with high mortality and treatment costs.
• Developing novel therapeutic platforms for cancer treatment remains a critical need.
• The use of microorganisms, particularly bacteria, is emerging as a promising strategy in cancer therapy.

Purpose of the Study:

• To review various bacteriocins with potential anti-cancer properties.
• To highlight the mechanisms by which bacteriocins can suppress tumor growth.
• To explore the clinical potential of bacteriocins in cancer treatment.

Main Methods:

• Literature review of studies on bacteriocins and their anti-cancer activities.
• Analysis of molecular and cellular signaling pathways affected by bacteriocins.
• Summary of different types of bacteriocins with demonstrated anti-cancer effects.

Main Results:

• Bacteria can produce a diverse array of anti-cancer agents, including bacteriocins.
• Bacteriocins exhibit potent anti-cancer properties due to their ability to activate or inhibit specific cellular and molecular signaling pathways.
• Several bacteriocins, such as colicins, nisins, pediocins, pyocins, and bovocins, have shown efficacy in suppressing tumor growth across various cancer stages.

Conclusions:

• Bacteriocins represent a class of potent anti-cancer agents with significant therapeutic potential.
• Further identification and characterization of bacteriocins could lead to their successful integration into clinical cancer treatment strategies.
• Bacteriocin-based therapies offer a novel approach to combatting various forms of cancer.